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Abstract The mosquito-borne Japanese encephalitis
virus (JEV) causes encephalitis in man but not in pigs.
Complete genomes of a human, mosquito and pig isolate
from outbreaks in 1982 and 1985 in Thailand were
sequenced with the aim of identifying determinants of
virulence that may explain the differences in outcomes of
JEV infection between pigs and man. Phylogenetic analysis
revealed that ﬁve of these isolates belonged to genotype I,
but the 1982 mosquito isolate belonged to genotype III.
There was no evidence of recombination among the Thai
isolates, but there were phylogenetic signals suggestive of
recombination in a 1994 Korean isolate (K94P05). Two
sites of the genome under positive selection were identi-
ﬁed: codons 996 and 2296 (amino acids 175 of the non-
structural protein NS1 and 24 of NS4B, respectively). A
structurally signiﬁcant substitution was seen at NS4B
position 24 of the human isolate compared with the mos-
quito and pig isolates from the 1985 outbreak in Thailand.
The potential importance of the two sites in the evolution
and ecology of JEV merits further investigation.
Abbreviation
KPP Kamphaeng Phet Province
Introduction
Japanese encephalitis virus (JEV) is a signiﬁcant cause of
epidemic encephalitis in people throughout Asia. The virus
is a member of the Japanese encephalitis (JE) serogroup of
the genus Flavivirus, family Flaviviridae, which also
includes West Nile virus (WNV), St Louis encephalitis
virus (SLEV) and dengue virus. These ﬂaviviruses consist
of a glycoprotein-containing lipid envelope surrounding a
nucleocapsid, which encloses one molecule of single-
stranded positive-sense RNA [2]. This 11-kb molecule
comprises 50 and 30 untranslated regions (UTRs), between
which a single open reading frame encodes seven non-
structural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b
and NS5) and three structural proteins: capsid (C); pre-
membrane (prM); envelope (E).
It is thought that JEV evolved from an ancestral virus in
the Indonesia-Malaysia region [30]. Based on nucleotide
sequencing of the C/prM and E genes, four genotypes of
JEV have been identiﬁed; the complete genomes of rep-
resentatives of each genotype have been sequenced. A
single member of a putative ﬁfth genotype has been iden-
tiﬁed [34]. No viruses belonging to genotype IV have been
isolated outside the Indonesia-Malaysia region, whereas
genotypes I to III have spread across Asia. Relatively
recently, virus belonging to genotype II has encroached
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quently, genotype I viruses have appeared in the Austral-
asian region [27]. Analysis of E gene sequences has
previously identiﬁed ﬁve viruses as having recombinant
sequences between genotypes I and III or III and IV [11,
33].
JEV is transmitted by mosquitoes, principally of the
Culex species. Humans are incidental hosts that become
infected when they encroach upon the natural cycle of the
virus. Ardeid birds, including herons and egrets, act as
reservoir hosts, but infection rates in man are higher in
areas where pigs are kept; hence, pigs are regarded as
‘amplifying hosts’. Only a proportion of people infected
with JEV develop neurologic disease, and it is not a feature
of infection in pigs. The factors governing the development
of neurologic signs are poorly understood, but it is likely
that both the host’s innate immune responses and strain
virulence determinants play a role [31].
The aim of this study was to analyze the genome of JEV
for any indication of strain virulence determinants that
might underlie the difference in outcome of infection in
pigs on the one hand, and man on the other.
Materials and methods
Viruses
Two sets of three viruses (from a pig, human or mosquito)
isolated during outbreaks in 1982 and 1985 in Kamphaeng
Phet Province, Thailand, were selected because they had
undergone limited passage in the laboratory (Table S1).
RNA extraction, reverse transcription and PCR
(RT-PCR)
Viral RNA was extracted from 140 ll of cell-free tissue
culture supernatant using a QIAmp
 Viral RNA Mini Kit
(QIAGEN) according to the manufacturer’s guidelines.
Viral RNA (5 ll), 10 pmol antisense primer (Table S2) and
500 lM each dNTP (Roche Applied Sciences) in a 12-ll
volume were heated to 65C for 5 min and immediately
placed on ice. After chilling on ice, a master mix con-
taining 4 ll of 5x ﬁrst-strand buffer, 10 mM DTT and 40 U
ribonuclease inhibitor (all from Invitrogen) was added to
each tube. Superscript I reverse transcriptase (200 U) was
added after 2 min during incubation at 42C for 65 min,
which was followed by incubation at 70C for 5 min.
Finally, RNA was digested by incubation at 37C for
20 min with 2 U RNase H (Invitrogen).
PCR was carried out with 3–8 ll cDNA template, 400
nM primers, 200 lM each dNTP, 2.5 ll 10x polymerase
buffer and 0.5 U Taq DNA polymerase (Promega) in a
25-ll volume. After an initial denaturation step at 94C for
5 min, cycling parameters (annealing temperature and time
for extension and number of cycles) were varied with the
primer set used. A ﬁnal extension step of 72C for 5 min
was carried out. Products of ampliﬁcation were evaluated
by electrophoresis in a 1.5% agarose gel in 0.04 M Tris/
acetate/0.001 M EDTA (TAE) buffer. DNA bands visual-
ized by ethidium bromide staining and UV transillumina-
tion were excised from the agarose gel and puriﬁed using a
QIAquick Gel Extraction Kit (QIAGEN).
Sequencing
Puriﬁed DNA products were ligated into the pGEM
-T
Easy vector (Promega), and ligated plasmids were intro-
duced into DH5a competent Escherichia coli through
chemical transformation. Transformed cells were spread
onto LB/ampicillin/IPTG/X-Gal plates and incubated
overnight at 37C. Individual white colonies were used to
inoculate 3 ml LB broth. After overnight incubation at
37C with shaking, plasmid DNA was extracted from 1 to
2 ml using a S.N.A.P. MiniPrep Kit (Invitrogen). To verify
the presence of DNA inserts, extracted plasmid DNA was
digested with EcoRI and examined by agarose gel
electrophoresis.
Sequencing reactions were performed by Lark Tech-
nologies, Essex, UK, on an ABI 3130 Genetic Analyzer
(Applied Biosystems). At least two independent plasmid
preparations were sequenced using M13 forward and
reverse primers. If there was disagreement between the two
plasmids, a third was sequenced to obtain a consensus. All
sequences were conﬁrmed by direct sequencing of puriﬁed
RT-PCR products using the virus-speciﬁc primers used for
ampliﬁcation.
Phylogenetic analysis
Complete genome sequences were obtained for the six JEV
isolates from Kamphaeng Phet Province (KPP), Thailand,
and aligned with complete genome sequences available on
GenBank for which the year of isolation was known,
excluding vaccine strains or other laboratory-derived
mutant strains (Table 1). The sequences were aligned using
Clustal W version 1.83 [5] and manually edited to obtain
the codon region frame only. The general time-reversible
(GTR) model with gamma distributed rate variation among
sites was identiﬁed as the appropriate nucleotide substitu-
tion model for phylogenetic analysis using the Findmodel
implementation of MODELTEST [26]. Phylogenetic trees
were constructed using PAUP* v4.0b10 [32] and FigTree
version 1.1 [28]. An initial phylogenetic tree to identify
genotypes was constructed using neighbor-joining (NJ).
The tree topology was conﬁrmed using maximum-
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123likelihood with tree bisection-reconnection and nearest-
neighbor interchange perturbations. Bootstrap analysis
(1000 replicates) was performed to assess the reliability of
branches.
To identify any conﬂicting signals in the complete
genome sequences that may indicate recombination, a
phylogenetic network was constructed using SplitsTree 4
version 4.10 [13]. To conﬁrm evidence of potential
recombination, potential parental sequences were identiﬁed
using RDP3 [21], and a similarity plot was generated using
the Kimura two-parameter method in Simplot version 3.5.1
[19], applying a window size of 400 bp and a step size of
50 bp.
Simplot was used to ‘slice’ alignments containing
putative recombinant and non-recombinant strains repre-
senting the different genotypes at the identiﬁed
breakpoints. Phylogenetic trees were constructed for the
different segments of each recombinant using the NJ
method, and bootstrap values for 1000 replicates were used
to assess the support for clustering of segments with strains
of different genotypes.
To determine the gene- and site-speciﬁc selection
pressures acting on the JEV genome, three different codon-
based maximum-likelihood methods, SLAC, FEL and REL
within the HYPHY software package as implemented in
Datamonkey (www.datamonkey.org) with signiﬁcance
levels set at p = 0.1, p = 0.1 and Bayes factor = 50,
respectively, were used to estimate the rate of nonsyn-
onymous (dN) and synonymous (dS) substitutions at each
codon site.
Results
Viruses from different genotypes co-circulated
in Kamphaeng Phet Province, Thailand in 1982
The reconstructed phylogeny showed that ﬁve of the six
isolates from KPP, Thailand, belonged to genotype I, but
the mosquito isolate from 1982 (KPP82-39-214CT)
belonged to genotype III (Fig. 1). This resulted in only one
set of isolates being available for comparison of the gen-
omes of viruses isolated from the three different species
(mosquito, man and pig) during the same outbreak.
There were 15 amino acid differences among the 1985
mosquito, pig and human isolate sequences (Table 2). The
mosquito isolate was distinct at three amino acid positions,
thepigisolateatﬁve,andthe1985humanisolatewasdistinct
from the pig and mosquito isolates at seven amino acid
positions. Two of the seven changes in the human isolate
werenon-conservative(P24SintheNS4BproteinandA97T
in the NS2A protein). The 50UTR sequences were identical,
buttherewerenine nucleotidedifferencesamongthe 30UTR
sequences: four unique to the isolate from a pig (10406:
T?C, 10419: C?T, 10426: A?G, 10560: G?A), three
unique to mosquito (10559: A?G, 10675: T?C, 10775:
C?T) and two unique to the human isolate (10686: T?C,
10786: A?G). None of these lie in the structural elements
identiﬁed by Olsthoorn and Bol [25].
There were three amino acid substitutions between the
pig and human isolates from the 1982 outbreak: A122T in
the capsid protein, G306E in the envelope protein, and
G354E in NS3. There were no substitutions in the
untranslated regions.
Korean isolate identiﬁed as a recombinant
The co-circulation of two distinct genotypes during the
same year in the same region suggested that the conditions
Table 1 Complete genome sequences included in phylogenetic
analysis
Strain Year of
isolation
Country Species Accession
no.
Nakayama 1935 Japan Human EF571853
Beijing-1 1949 China Human L48961
P3 1949 China Mosquito U47032
SA14 1954 China Mosquito U14163
Vellore P20778 1958 India Human AF080251
HVI 1958 Taiwan Human AF098735
JaGAr01 1959 Japan Mosquito AF069076
Ling 1965 Taiwan Human L78128
TL 1965 Taiwan Human AF098737
JaOH0566 1966 Japan Human AY508813
GP78 1978 India Human AF075723
JKT-6468 1981 Indonesia Mosquito AY184212
JaOArS982 1982 Japan Mosquito M18370
KPP82-39-214CT 1982 Thailand Mosquito GQ902063
a
B0860/82 1982 Thailand Pig GQ902058
a
1070/82 (Subin) 1982 Thailand Human GQ902059
a
3KP’U’CV569 1985 Thailand Mosquito GQ902060
a
B1381-85 1985 Thailand Pig GQ902061
a
4790-85 1985 Thailand Human GQ902062
a
K87P39 1987 Korea Mosquito AY585242
CH1392 1990 Taiwan Mosquito AF254452
Ishikawa 1994 Japan Pig AB051292
K94P05 1994 Korea Mosquito AF045551
FU 1995 Australia Human AF217620
T1P1 1997 Taiwan Mosquito AF254453
KV1899 1999 Korea Pig AY316157
JEV/Sw/Mie/
41/2002
2002 Japan Pig AB241119
JEV/Sw/Mie/
40/2004
2004 Japan Pig AB241118
a Indicates complete genome sequences obtained as part of this study
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123existed for detectable recombination. As recombinant
sequences can lead to aberrant results in phylogenetic
analysis, Splits Tree analysis was performed to identify any
potential recombinants. There was no evidence of discor-
dant relationships among the six isolates from Thailand
sequenced for this study. However, a net-like pattern at the
node linking K94P05, a virus isolated from a mosquito in
Korea in 1994, to the rest of the tree is typical of conﬂicting
phylogenetic signals in the data that may be caused by
recombination (Fig. 2).
Analyses using programs available within RDP3 (RDP,
Genescan, Bootscan, MaxChi, Chimaera, SiScan and 3Seq)
all suggested that K94P05 is a recombinant and that the
strains closest to the likely major and minor parents were
Ishikawa (a genotype 1 strain) and JaOArS982 (a genotype
III strain), respectively. A similarity plot of the complete
genome sequence of K94P05 compared with Ishikawa and
JaOArS982 suggested that recombination had occurred in
K94P05 between nucleotides 8822 and 9246, in the NS5
gene (Fig. 3). When NJ trees were generated using seg-
ments of the region on either side of the identiﬁed break-
points, bootstrap support (n = 1000) for K94P05 clustering
with genotype I strains was 100% for nucleotide segments
1–8822 and 9247–10982, and for K94P05 clustering with
genotype III strains, it was 99% for the region 8823–9246
(Fig. 4).
Positive selection identiﬁed in NS1 and NS4B
The ratio of dN to dS substitutions per nucleotide site was
estimated from an alignment of 27 complete genomes
(the putative recombinant, K94P05, was excluded from the
analysis). The predominant selective pressure acting on the
JEV genome was purifying (i.e., negative selection),
reﬂected in a dN/dS value of less than one. For example, in
SLAC (p = 0.1), 22% of codons were under negative
selection pressure. Seven sites were identiﬁed as under
positive selection by integrative analysis. Two of these
sites, codon 969–972 (amino acid 174 of NS1) and codon
2296–2298 (amino acid 24 of NS4B) were identiﬁed as
under positive selection pressure by FEL (p-value \0.1)
and had p-values of\0.3 and\0.2, respectively, by SLAC
(Table 3).
The different combinations of amino acids encoded at
codons 969 and 2296 cluster according to genotype, i.e.,
they are phylogenetically informative (Fig. 1). The geno-
type III viruses (with the exception of Beijing and Ling)
had serine at 969 and 2296. There was more variation
Ishikawa (P)
JEV/Sw/Mie/41/2002 (P)
JEV/Sw/Mie/40/2004 (P)
KV1899 (P)
K94P05 (M)
4790/85  (H)
B1381/85  (P)
3KP’U’CV569  (M)
B0860/82  (P)
1070/82  (H)
FU (H)
P20778 (H)
Ling (H)
Beijing-1 (M)
Nakayama (H)
K87P39 (M)
CH1392 (M)
T1P1 (M)
JaGAr01 (M)
JaOH0566 (H)
TL (H)
HV1 (H)
P3 (H)
JaOArS982 (M)
SA14 (H)
KPP82-39-214CT (M)
GP78 (H)
JKT6468 (M)
0.02
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Fig. 1 Phylogenetic tree of complete genomes of 28 Japanese
encephalitis virus isolates. The six isolates from KPP, Thailand,
sequenced for this study are highlighted in bold text, and the host
species is indicated after the strain names (H, human; M, mosquito; P,
pig). Amino acid combinations present at codons 996 and 2296 are
indicated by symbols. Percent bootstrap values (n = 1000) of major
nodes are indicated. The genotype IV isolate JKT6468 was used as an
outgroup. Bar, 0.02 nucleotide substitutions per site
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123among the genotype I strains with the ﬁve genotype I KPP
strains forming a separate sub-clade within the genotype.
All ﬁve KPP strains had negatively charged aspartic acid at
969 (all other isolates had arginine or serine), and four of
the isolates had proline at 2296, whereas the human 1985
isolate (4790/85) had serine at 2296.
Discussion
In the present study, we demonstrated that, in Thailand, the
conditions exist (that is, the co-circulation of genetically
distinguishable strains of virus) for detectable recombina-
tion to occur in JEV. Co-circulation of genotypes I and III
strains in the same country at the same time has been
reported previously in China [35] and in Japan [15].
Analysis of available complete genome sequences of
natural strains of JEV provided evidence of recombination
in one of 28 isolates. RNA virus recombination was ﬁrst
detected in poliovirus [16] and has since been demon-
strated in members of the family Flaviviridae. Recombi-
nants were identiﬁed in all four serotypes of dengue virus
[1, 3, 33, 37] and SLEV [33]. Recombination in the
envelope protein has also been described previously for
JEV [11, 33]. This is the ﬁrst report of recombination
detected in JEV from a complete genome analysis.
Viruses may be erroneously identiﬁed as recombinants
[9], for example as a result of labeling errors in the
Table 2 Amino acid changes among viruses isolated from a mosquito, human or pig during 1985 in Kamphaeng Phet Province, Thailand
Strain (species of origin) Capsid Envelope NS1 NS2A NS4B NS5
51 52 113 116 120 123 434 206 251 97 179 24 108 830 889
3KP0U0CV569 (Mosquito) Ile Thr Met Ala Ser Ser Phe Leu Lys Ala Thr Pro Ala Met Ile
B1381/85 (Pig) Val Ala Val Ala Ser Ser Phe Phe Arg Ala Ile Pro Ala Thr Thr
4790/85 (Human) Ile Thr Met Val Thr Asn Leu Leu Arg Thr Ile Ser Val Met Thr
Bold typeface indicates occurrence of a different amino acid
JEV/Sw/Mie/41/2002
JEV/Sw/Mie/40/2004
KV1899
K94P05
K87P39
KPP82-39-214CT
GP78
JaOArS982
SA14
P3 JaOH0566
T1P1
CH1392
JaGAr01
HV1
TL
Ling
Beijing
Nakayama
P20778 (Vellore)
JKT6468
FU
B0860/82
1070-82
3KP'U'CV569
4790/85
B1381/85
Ishikawa
0.01
(IV)
(II)
(I)
(III)
Fig. 2 Splits Tree analysis of
complete genomes of 28
Japanese encephalitis virus
isolates. The names of the six
isolates from KPP, Thailand, are
in italics, and the putative
recombinant strain K94P05 is
highlighted in bold text. Bar,
0.01 nucleotide substitutions per
site
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123laboratory or if sequence is acquired from an uncloned
virus. Unfortunately, the K94P05 strain identiﬁed as a
putative recombinant in this study was not available for the
presence of recombination to be conﬁrmed by independent
sequencing. The published sequence was reported to have
been conﬁrmed by an independent PCR ampliﬁcation, and
if discrepancies were found between the two sequence
results, a third independent PCR ampliﬁcation was per-
formed to determine the sequence [24]. In their study of
recombination in ﬂaviviruses using E gene sequence data
published in GenBank, Twiddy and Holmes (2003) iden-
tiﬁed 3 of 49 strains analyzed as recombinants. Interest-
ingly, two of these were also isolated in Korea, in 1982
(K82P01) and 1991 (K91P55) [33]. Twiddy and Holmes
(2003) report the ‘parents’ of the two putative recombi-
nants from Korea as genotype I and II strains, but they
assigned the viruses to genotypes differently to other
authors [4, 30, 34]. Their genotypes I and II are equivalent
to genotypes I and III, respectively, in the nomenclature of
Chen et al. [4], which is the nomenclature adopted in this
study. Further support for the occurrence of recombination
in JEV in nature comes from a study in which JEV
recombinants were generated in vitro by co-infection of
cells with two plaque-puriﬁed virus strains [6]. Recombi-
nation ‘hot spots’ of AU-rich sequences have been identi-
ﬁed in other viruses with single-strand positive-sense
genomic RNA [29]. Stretches of AU-rich sequence were
identiﬁed on either side of the putative recombination
breakpoints in the NS5 gene of K94P55 (unpublished data).
As a putative recombinant, the sequence of K94P55 was
excluded from subsequent analyses for selection pressures.
The strongest evidence for positive selection in the JEV
genome was at the codon for amino acid 24 of NS4B
(codon 2296). Of note was the ﬁnding that there is a non-
conservative amino acid change in the Thai human isolate
from 1985 (4790/85) at this position; the mosquito and pig
isolates had proline, and the human isolate had serine.
However, the majority of genotype III strains, including
viruses isolated from mosquitoes and another genotype I
strain (KV1899), also had serine at position 2296. The
substitution in 4790/85 may nonetheless be signiﬁcant—no
other isolate had the same combination of D996 and S2296.
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Fig. 3 Simplot comparison of complete genome sequences of
K94P05, Ishikawa and JaOArS982. The x-axis indicates the nucle-
otide position, and the y-axis, the percent nucleotide similarity
between the sequence of the putative recombinant K94P05 and each
parent, plotted at the midpoint of the window. The window size was
400 bp, and the increment was 50 bp
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123NS4B has been shown to play a role as an interferon (IFN)
antagonist in dengue virus [22, 23] and WNV [10]. In light
of these observations, examining the effects of substitution
at codon 2296 on replication in IFN-competent versus
deﬁcient cells using an infectious clone may provide
interesting data.
A second site of positive selection was identiﬁed at
amino acid 175 of the NS1 protein, within a cluster of
negatively charged residues (169-KITEEDTDECD-179).
Such clusters of residues are generally located on the sur-
face of proteins. Substitution of an uncharged amino acid
(e.g., asparagine or serine found in the majority of isolates)
Genotype III
Genotype II
Genotype IV
Genotype I
100%
(a)
Genotype III
Genotype I
99%
Genotype II
Genotype IV
(b)
Genotype III
Genotype II
Genotype IV
Genotype I
100%
(c)
0.02
0.02
0.02
Fig. 4 Phylogenetic trees showing shifts in phylogenetic position of
segments of K94P05 on either side of the putative breakpoints:
nucleotides 1–8822 (a), 8823–9246 (b), and 9247–10,982 (c). Percent
bootstrap support (n = 1000) for the putative recombinant strain
K94P05 (highlighted in a square text box) clustering with different
genotypes is indicated. The trees are unrooted, and branch lengths are
drawn to scale. The genotype IV isolate JKT6468 was used as an
outgroup
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123for a charged amino acid (e.g., aspartic acid found in the
ﬁve genotype I KPP isolates) within this region could
potentially interrupt protein–protein interactions. NS1 is
required for viral replication [18], and high levels are
produced during ﬂavivirus infection, resulting in the pro-
duction of speciﬁc antibodies [14, 17, 20]. It has also
recently been shown to have a potential role in immuno-
modulation [7, 8, 36].
In summary, using a bioinformatics approach, evidence
of recombination in a JEV isolate from Korea was detec-
ted. Also, two regions of the JEV genome, in the NS1 and
NS4B genes, that are under positive selection were iden-
tiﬁed. These may warrant further investigation.
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